New York, New York – (Newsfile Corp. – December 20, 2024) – WHYRosen Law Firm, a global investor rights law firm, announces an investigation into potential securities claims on behalf of shareholders of AstraZeneca PLC (NASDAQ: LON:) arising from allegations that AstraZeneca (NASDAQ:) may have provided materially misleading business information to the has issued public investment.
SO AND: If you purchased AstraZeneca securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. Rosen Law Firm is preparing a class action lawsuit to recover investor losses.
WHAT TO DO NEXT: To join the prospective class action, go to https://rosenlegal.com/submit-form/?case_id=1331 or call Phillip Kim, Esq. to. Call us toll-free at 866-767-3653 or email cases@rosenlegal.com for class action information.
What is this about: On October 30, 2024, AstraZeneca announced that Leon Wang, Executive Vice President International and President of AstraZeneca China, was “cooperating with an ongoing investigation by Chinese authorities.”
On this news, AstraZeneca American Depositary Shares (“ADS”) fell 3.1% on October 30, 2024.
Then, on November 5, 2024, Yicai Global published an article titled “AstraZeneca insurance fraud affects dozens of senior executives in China, source says.” That article stated that “According to a person familiar with the matter, dozens AstraZeneca China senior executives have been involved in an ongoing insurance fraud case since last week.” It also said that “insurance fraud cases involving AstraZeneca have occurred over the past three years Shenzhen as well as in the provinces of Fujian and Jiangxi. (…) These cases represent the largest insurance fraud in the country.” A person familiar with the matter emphasized that she has been working in the pharmaceutical industry for years.
On this news, AstraZeneca’s ADSs fell 7.2% on November 5, 2024.
WHY ROSEN LAW: We encourage investors to select qualified advisors who have a track record of success in leadership roles. Companies issuing notices often do not have comparable experience, resources, or significant peer recognition. Many of these firms do not conduct securities class actions. Be smart when choosing your advisor. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. At that time, Rosen Law Firm achieved the largest ever securities class action settlement against a Chinese company. Rosen Law Firm was Ranked No. 1 by the ISS Securities Class action (WA:) Services for the number of securities class action settlements in 2017. The company has ranked in the top 4 every year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone, the company secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named a Titan of Plaintiffs’ Bar by law360. Many of the firm’s attorneys have been recognized by Lawdragon and Super Lawyers.
For updates, follow us on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook (NASDAQ:): https: / /www.facebook.com/rosenlawfirm/.
Lawyer advertising. Previous results do not guarantee a similar result.
—————–
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/234859
